menu
    • menu

    Company profile for Secretome Therapeutics

    NEW Drugs in Dev: 2
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Secretome Therapeutics is focused on revolutionizing the treatment of life-threatening diseases by utilizing neonatal cardiac progenitor cells (nCPCs). The company’s mission is to improve patient outcomes through innovative scientific advancements, scalable solutions, and targeted therapies that aim to transform lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Secretome TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    323 W. Camden Street, Suite 600 Baltimore, MD 21201
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://secretometherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Secretome Therapeutics Raises $30M Series A for STM-01
    Secretome Therapeutics Raises $30M Series A for STM-01

    27 May 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260527439636/en/Secretome-Therapeutics-Announces-%2430-Million-Series-A-Financing-From-RA-Capital-Management-to-Advance-STM-01-for-Duchenne-Associated-Cardiomyopathy

    BUSINESSWIRE
    27 May 2026
    Share Share
    Secretome Therapeutics to Participate in Summer Investor Conf
    Secretome Therapeutics to Participate in Summer Investor Conf

    15 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-15/secretome-therapeutics-announces-participation-in-upcoming-summer-investor-conferences

    PHARMIWEB
    15 May 2026
    Share Share
    Secretome Therapeutics To Participate In Investor Conferences
    Secretome Therapeutics To Participate In Investor Conferences

    27 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-27/secretome-therapeutics-announces-participation-in-upcoming-investor-conferences

    PHARMIWEB
    27 Mar 2026
    Share Share
    PPMD Awards Secretome Therapeutics $250K for Cardiac Cell Therapy
    PPMD Awards Secretome Therapeutics $250K for Cardiac Cell Therapy

    24 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/ppmd-provides-250-000-in-funding-to-secretome-therapeutics-through-ppmd-venture-pathways-program-to-support-development-of-cardiac-cell-therapy-302723532.html

    PR NEWSWIRE
    24 Mar 2026
    Share Share
    Secretome Therapeutics To Present At 2026 J.P. Morgan Health Conf
    Secretome Therapeutics To Present At 2026 J.P. Morgan Health Conf

    29 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251229134289/en/Secretome-Therapeutics-to-Present-at-the-2026-J.P.-Morgan-Healthcare-Conference

    BUSINESSWIRE
    29 Dec 2025
    Share Share
    Secretome Therapeutics Begins Phase 1 Trial For STM-01
    Secretome Therapeutics Begins Phase 1 Trial For STM-01

    28 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251028172791/en/Secretome-Therapeutics-Initiates-Phase-1-Clinical-Trial-of-STM-01-in-Patients-with-Dilated-Cardiomyopathy

    BUSINESSWIRE
    28 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search